Loading...
A phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1
Oh, DY Chen, LT He, AR Okusaka, T Qin, S Chin, S Rokutanda, N Uchinda, H Vogel, A Valle, Juan W
Oh, DY
Chen, LT
He, AR
Okusaka, T
Qin, S
Chin, S
Rokutanda, N
Uchinda, H
Vogel, A
Valle, Juan W
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Oh DY, Chen LT, He AR, Okusaka T, Qin S, Chin S, et al. 831TiP A phase III, randomized, double-blind, placebo-controlled, international study of durvalumab in combination with gemcitabine plus cisplatin for patients with advanced biliary tract cancers: TOPAZ-1. Annals of Oncology. 2019;30(Supplement_5):319.